3-5
2026
影响因子区间
107天
平台估算
16%
2025
中国作者发文占比
—
收费
期刊简介:Advances in Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all therapeutic areas. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Advances in Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.
【译文】《治疗进展》是一本国际性的、同行评审的、快速发表的(同行评审2周,接受后3-4周出版)期刊,致力于发表高质量的关于治疗药物和干预措施(包括设备)的发现、开发和使用的临床(所有阶段)、观察性、现实世界和健康结果研究。鼓励与诊断和诊断、药物经济学、公共卫生、流行病学、生活质量以及患者护理、管理和教育相关的研究。该期刊对广泛的医疗保健专业人员感兴趣,并发表原创研究、评论、通讯和信件。该期刊被全球读者阅读,并接受来自世界各地的投稿。无论研究结果是积极的、确认性的还是消极的,只要科学合理,《治疗进展》都会考虑。欢迎与国际和/或特定国家受众相关的研究投稿,这对于研究人员试图针对更具体的患者群体至关重要。这种包容性方法使期刊能够帮助传播所有科学和伦理上合理的研究。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 影响因子区间 | 3-5 | 暂无 |